In this program, experts in MDD discuss approaches to recognizing and resolving EB to help patients toward full functional recovery. Panelists reflect on verbatim perspectives of patients who have experienced MDD-related EB to provide context and a platform for scientific discussion of faculty strategies.

Assess the pathophysiology and rationale for the early diagnosis of Alzheimer’s disease (AD). 

Devise practical approaches to implement outreach programs to enhance early recognition and diagnosis of MCI/AD in underserved populations, including strategies for engagement and support of caregivers.

Expert faculty will discuss risk factors for and identification of Tardive Dyskinesia, treatment recommendations according to current guidelines. and the latest evidence on emerging therapies and conclude with the potential impact of clinical trial data on patients’ lives.